HDAC-话题@MedSci

#HDAC#

35篇内容 | 1465人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2003429, encodeId=b9a6200342909, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Clin Cancer Res：HDAC抑制剂Remetinostat凝胶用于基底细胞癌的治疗活性, objectType=article, longId=216890, objectId=3239216890aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3239216890aa, replyNumber=0, likeNumber=83, createdTime=2021-10-26, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3239216890aa, moduleTitle=Clin Cancer Res：HDAC抑制剂Remetinostat凝胶用于基底细胞癌的治疗活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3239216890aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003430, encodeId=8a7e20034307e, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1, objectType=article, longId=220880, objectId=1f00220880cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f00220880cb, replyNumber=0, likeNumber=74, createdTime=2022-09-28, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f00220880cb, moduleTitle=miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f00220880cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003428, encodeId=597d200342825, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Cell Death Dis：LncRNA kcnq1ot1通过介导miR-452-3p/HDAC3/ABCA1通路促进脂质的积累并促进动脉粥样硬化, objectType=article, longId=204914, objectId=e0202049141f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0202049141f, replyNumber=0, likeNumber=88, createdTime=2021-02-28, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0202049141f, moduleTitle=Cell Death Dis：LncRNA kcnq1ot1通过介导miR-452-3p/HDAC3/ABCA1通路促进脂质的积累并促进动脉粥样硬化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0202049141f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003426, encodeId=2ba0200342618, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Cell Death Differ：HDAC3异常表达抑制Klotho的转录促进肾纤维化的发生发展, objectType=article, longId=202097, objectId=534c20209e94, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=534c20209e94, replyNumber=0, likeNumber=101, createdTime=2021-08-22, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=534c20209e94, moduleTitle=Cell Death Differ：HDAC3异常表达抑制Klotho的转录促进肾纤维化的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=534c20209e94)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003425, encodeId=5d94200342542, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Nature：肠道微生物代谢产物新功能，促进HDAC3酶活性, objectType=article, longId=199586, objectId=1aa9199586aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aa9199586aa, replyNumber=0, likeNumber=75, createdTime=2020-10-09, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aa9199586aa, moduleTitle=Nature：肠道微生物代谢产物新功能，促进HDAC3酶活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aa9199586aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003427, encodeId=9d1d200342e50, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Clin Cancer Res：HDAC和mTOR联合抑制大大改善复发/难治性霍奇金淋巴瘤患者预后, objectType=article, longId=202902, objectId=3b6b202902d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b6b202902d9, replyNumber=0, likeNumber=92, createdTime=2021-05-30, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b6b202902d9, moduleTitle=Clin Cancer Res：HDAC和mTOR联合抑制大大改善复发/难治性霍奇金淋巴瘤患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b6b202902d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003424, encodeId=f537200342496, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=【Nature】免疫“阴阳”谁调控？HDAC3蛋白是关键, objectType=article, longId=198924, objectId=ec93198924aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec93198924aa, replyNumber=0, likeNumber=83, createdTime=2021-03-27, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec93198924aa, moduleTitle=【Nature】免疫“阴阳”谁调控？HDAC3蛋白是关键, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec93198924aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003421, encodeId=1082200342182, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=J Cell Mol Med：去纤蛋白肽可防止HDAC的上调, objectType=article, longId=188930, objectId=99181889301a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99181889301a, replyNumber=0, likeNumber=0, createdTime=2020-09-30, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99181889301a, moduleTitle=J Cell Mol Med：去纤蛋白肽可防止HDAC的上调, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99181889301a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003423, encodeId=9078200342323, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=张清媛教授专访：从淋巴瘤到乳腺癌，HDAC抑制剂西达本胺在实体肿瘤迎来突破, objectType=article, longId=194406, objectId=5ae119440659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ae119440659, replyNumber=0, likeNumber=0, createdTime=2020-06-05, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ae119440659, moduleTitle=张清媛教授专访：从淋巴瘤到乳腺癌，HDAC抑制剂西达本胺在实体肿瘤迎来突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ae119440659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003419, encodeId=8f58200341972, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤, objectType=article, longId=187714, objectId=782818e714bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=782818e714bf, replyNumber=0, likeNumber=82, createdTime=2021-01-06, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=782818e714bf, moduleTitle=Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=782818e714bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003416, encodeId=348f2003416d4, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Cell Rep │ 史隽课题组揭示3个全新的HDAC4酶活性底物及其在肌肉萎缩症中的重要作用, objectType=article, longId=181355, objectId=8283181355a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8283181355a9, replyNumber=0, likeNumber=88, createdTime=2020-03-05, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8283181355a9, moduleTitle=Cell Rep │ 史隽课题组揭示3个全新的HDAC4酶活性底物及其在肌肉萎缩症中的重要作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8283181355a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003422, encodeId=6a8f2003422d7, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Cell Death Dis：miR-143通过抑制HDAC7促进血管生成及成骨细胞的分化, objectType=article, longId=190571, objectId=ec181905e11b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec181905e11b, replyNumber=0, likeNumber=116, createdTime=2020-04-01, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec181905e11b, moduleTitle=Cell Death Dis：miR-143通过抑制HDAC7促进血管生成及成骨细胞的分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec181905e11b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003415, encodeId=425920034158d, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Xynomic公司宣布其HDAC抑制剂Abbexinostat与Keytruda联合治疗多种实体瘤的阳性1b期研究中期数据, objectType=article, longId=178550, objectId=07b01e855010, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07b01e855010, replyNumber=0, likeNumber=127, createdTime=2020-06-12, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07b01e855010, moduleTitle=Xynomic公司宣布其HDAC抑制剂Abbexinostat与Keytruda联合治疗多种实体瘤的阳性1b期研究中期数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07b01e855010)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003417, encodeId=db96200341e90, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Blood：HDAC11抑制剂，骨髓增生性肿瘤的新选择, objectType=article, longId=183497, objectId=462318349ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=462318349ea8, replyNumber=0, likeNumber=93, createdTime=2020-03-17, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=462318349ea8, moduleTitle=Blood：HDAC11抑制剂，骨髓增生性肿瘤的新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=462318349ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003418, encodeId=aa5e2003418f8, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Sci Transl Med：HDAC抑制剂SAHA可改善心衰患者的心脏结构和功能, objectType=article, longId=186158, objectId=6a4918615898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a4918615898, replyNumber=0, likeNumber=112, createdTime=2020-07-31, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a4918615898, moduleTitle=Sci Transl Med：HDAC抑制剂SAHA可改善心衰患者的心脏结构和功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a4918615898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003420, encodeId=a89520034206d, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Blood：FLT3抑制上调HDAC8使p53失活，维持FLT3-ITD+ AML细胞存活, objectType=article, longId=188122, objectId=ed321881228a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed321881228a, replyNumber=0, likeNumber=120, createdTime=2020-12-08, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed321881228a, moduleTitle=Blood：FLT3抑制上调HDAC8使p53失活，维持FLT3-ITD+ AML细胞存活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed321881228a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003411, encodeId=3363200341127, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=基石药业HDAC6抑制剂CS3003在中国I期临床试验获批, objectType=article, longId=162295, objectId=862416229577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=862416229577, replyNumber=0, likeNumber=0, createdTime=2020-02-09, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=862416229577, moduleTitle=基石药业HDAC6抑制剂CS3003在中国I期临床试验获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=862416229577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003412, encodeId=8da52003412d2, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Viracta的HDAC抑制剂nanatinostat治疗EBV相关癌症，获得美国FDA的孤儿药物指定, objectType=article, longId=164502, objectId=df0c164502be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df0c164502be, replyNumber=0, likeNumber=79, createdTime=2019-12-20, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df0c164502be, moduleTitle=Viracta的HDAC抑制剂nanatinostat治疗EBV相关癌症，获得美国FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df0c164502be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003414, encodeId=e84220034144c, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Circulation：HDAC4的糖基化修饰可降低糖尿病患者的心衰风险, objectType=article, longId=177977, objectId=9ef81e79778c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ef81e79778c, replyNumber=0, likeNumber=75, createdTime=2019-09-27, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ef81e79778c, moduleTitle=Circulation：HDAC4的糖基化修饰可降低糖尿病患者的心衰风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ef81e79778c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003413, encodeId=9469200341352, content=<a href='/topic/show?id=86d585931d' target=_blank style='color:#2F92EE;'>#HDAC#</a>, objectTitle=Stem Cells Transl Med：HDAC8可调节纤维异常增生中骨髓基质细胞的增殖和分化, objectType=article, longId=165090, objectId=ae00165090a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae00165090a7, replyNumber=0, likeNumber=0, createdTime=2020-02-06, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae00165090a7, moduleTitle=Stem Cells Transl Med：HDAC8可调节纤维异常增生中骨髓基质细胞的增殖和分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae00165090a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HDAC

2020-05-29

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Clin Cancer Res：HDAC抑制剂Remetinostat凝胶用于基底细胞癌的治疗活性

2021-10-26

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1

2022-09-28

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Cell Death Dis：LncRNA kcnq1ot1通过介导miR-452-3p/HDAC3/ABCA1通路促进脂质的积累并促进动脉粥样硬化

2021-02-28

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Cell Death Differ：HDAC3异常表达抑制Klotho的转录促进肾纤维化的发生发展

2021-08-22

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Nature：肠道微生物代谢产物新功能，促进HDAC3酶活性

2020-10-09

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Clin Cancer Res：HDAC和mTOR联合抑制大大改善复发/难治性霍奇金淋巴瘤患者预后

2021-05-30

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

【Nature】免疫“阴阳”谁调控？HDAC3蛋白是关键

2021-03-27

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

J Cell Mol Med：去纤蛋白肽可防止HDAC的上调

2020-09-30

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

张清媛教授专访：从淋巴瘤到乳腺癌，HDAC抑制剂西达本胺在实体肿瘤迎来突破

2020-06-05

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤

2021-01-06

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Cell Rep │ 史隽课题组揭示3个全新的HDAC4酶活性底物及其在肌肉萎缩症中的重要作用

2020-03-05

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Cell Death Dis：miR-143通过抑制HDAC7促进血管生成及成骨细胞的分化

2020-04-01

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Xynomic公司宣布其HDAC抑制剂Abbexinostat与Keytruda联合治疗多种实体瘤的阳性1b期研究中期数据

2020-06-12

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Blood：HDAC11抑制剂，骨髓增生性肿瘤的新选择

2020-03-17

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Sci Transl Med：HDAC抑制剂SAHA可改善心衰患者的心脏结构和功能

2020-07-31

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Blood：FLT3抑制上调HDAC8使p53失活，维持FLT3-ITD+ AML细胞存活

2020-12-08

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

基石药业HDAC6抑制剂CS3003在中国I期临床试验获批

2020-02-09

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Viracta的HDAC抑制剂nanatinostat治疗EBV相关癌症，获得美国FDA的孤儿药物指定

2019-12-20

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Circulation：HDAC4的糖基化修饰可降低糖尿病患者的心衰风险

2019-09-27

lingaifan (审核中...)

前往app查看评论内容

#HDAC#

Stem Cells Transl Med：HDAC8可调节纤维异常增生中骨髓基质细胞的增殖和分化

2020-02-06

科室
- - 订阅+
  - 更多科室
工具
服务